Use and continuity of weight‐modifying medications among adults with diabetes and overweight/obesity: US population study is a dataset published in Obesity (2023). On theSindex it has a DataRank of 0.652, placing it in the top 30.5% of the data-sharing corpus. It has been cited 14 times, with 10 citing works in its 1-hop citation network.
Ranks in the top 31% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0.245
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 10 citers.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK123384
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: K23DK114497
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R03DK127010
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: 2P30DK111024
NIDDK NIH HHS
Grant: P30 DK111024
NCATS NIH HHS
Grant: UL1 TR002378
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals